Nebius's Clash of Signals: A £1.7 Billion UK AI Push Meets a $130 Million Insider Sell-Off

Insiders sold nearly 700,000 shares worth $130M, triggering a 17% weekly decline. Yet Nebius posts 684% revenue growth, $46B backlog, and deepens Nvidia ties.

On paper, Nebius has never looked stronger. The cloud infrastructure group is booking billions in orders, deepening a partnership with Nvidia, and positioning itself as a cornerstone of Britain's artificial intelligence ambitions. Yet the stock has lost nearly 17% in the past week alone, sliding to €180.58. The culprit lies in the executive suite.

Over the past three months, insiders have sold almost 700,000 shares, unloading paper worth roughly $130 million. That wave of profit-taking has unnerved the market, even as the operational story crackles with momentum. A previous week had already seen a 15% drop, with the shares touching €184.16 before the latest leg lower.

The numbers behind the sell-off are hard to ignore. Nebius expanded revenue by 684% in the first quarter, generated $130 million in adjusted operating profit, and now sits on a contract backlog worth $46 billion. Tech heavyweights including Meta and Microsoft have committed to multi-billion-dollar capacity deals, anchoring a pipeline that few upstarts can match.

To feed that demand, Nebius is pouring money into physical infrastructure. In the UK, the company has leased an entire campus from Ark Data Centres, which is investing over £800 million in new buildings. That sits alongside a broader £1.7 billion commitment to build nationwide AI computing capacity — a plan that aligns neatly with the government's own £1.1 billion hardware initiative.

A ten-year agreement with Kao Data secures a 22-megawatt facility in Harlow, with plans to scale to 65 megawatts by 2027. Every rack will run on Nvidia's latest chips, giving Nebius the kind of raw compute power that sensitive industries demand. Early adopters include fintech Revolut and biotech firm Prima Mente, using the platform to combat financial crime and accelerate drug development.

Alongside that, Nebius is planting a flag in robotics. In September 2026 it will launch the "Physical AI Living Lab" in Europe, granting robotics startups access to Nvidia's Blackwell chips and virtual simulation tools. Developers will train autonomous systems in digital worlds before deploying them in the physical realm — a niche that sets Nebius apart from generalist cloud providers.

On the stock front, the present correction has been brutal. The shares stand roughly 25% below a record high touched in early June. Still, the annual gain remains a staggering 293%, and the advance since January clocks in at 136% — or 140% on a year-to-date basis, depending on the metric used. Annualized volatility of 136% underscores the wild ride.

The market cap has swollen to nearly €50 billion, a far cry from the outfit that was once dismissed as a fringe player. Yet the tug-of-war among institutional investors is palpable. The Swedish pension fund AP4 recently used the pullback to build a new position. Some advisors have been adding heavily; others have followed the insider lead and taken chips off the table.

Technically, the stock still trades well above its 200-day moving average of €103.73, suggesting the long-term uptrend remains intact. Management has set a target of $9 billion in recurring revenue by the end of 2026 — a fivefold leap from current levels. If Nebius delivers those numbers, the insider exits may soon be remembered as a footnote to a much larger story.